EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic Targets

Robin Reschke iD, Alexander H Enk, Jessica C Hassel iD

International Journal of Molecular Sciences · 13.06.2024 · 25 (12) · 6532

DOI: 10.3390/ijms25126532 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.06.2024. Verfasst von Robin Reschke und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, 69120 Heidelberg, Germany. Hauptthemen laut MEDLINE: Immunotherapy, Melanoma, Chemokines, Cytokines. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Heidelberg University, German Cancer Aid, Clinician Scientist Programm of Heidelberg University, Faculty of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemokines and cytokines represent an emerging field of immunotherapy research. They are responsible for the crosstalk and chemoattraction of immune cells and tumor cells. For instance, CXCL9/10/11 chemoattract effector CD8+ T cells to the tumor microenvironment, making an argument for their promising role as biomarkers for a favorable outcome. The cytokine Interleukin-15 (IL-15) can promote the chemokine expression of CXCR3 ligands but also XCL1, contributing to an important DC-T cell interaction. Recruited cytotoxic T cells can be clonally expanded by IL-2. Delivering or inducing these chemokines and cytokines can result in tumor shrinkage and might synergize with immune checkpoint inhibition. In addition, blocking specific chemokine and cytokine receptors such as CCR2, CCR4 or Il-6R can reduce the recruitment of tumor-associated macrophages (TAMs), myeloid-derived suppressor cells (MDSCs) or regulatory T cells (Tregs). Efforts to target these chemokines and cytokines have the potential to personalize cancer immunotherapy further and address patients that are not yet responsive because of immune cell exclusion. Targeting cytokines such as IL-6 and IL-15 is currently being evaluated in clinical trials in combination with immune checkpoint-blocking antibodies for the treatment of metastatic melanoma. The improved overall survival of melanoma patients might outweigh potential risks such as autoimmunity. However, off-target toxicity needs to be elucidated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyMelanomaChemokinesCytokinesHumansBiomarkers, TumorTumor MicroenvironmentAnimalsNeoplasmsMolecular Targeted Therapy

Stichwörter der Autor:innen

chemokinescytokinesimmunotherapytumor microenvironment

Substanzen

ChemokinesCytokinesBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, 69120 Heidelberg, Germany.
  • German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, 69120 Heidelberg, Germany.

ORCID-Profile: Robin Reschke, Jessica C Hassel

Förderung

  • Heidelberg University
  • German Cancer Aid
  • Clinician Scientist Programm of Heidelberg University, Faculty of Medicine

Zitieren

APA

Reschke, R., Enk, A. H., & Hassel, J. C. (2024). Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic Targets. International Journal of Molecular Sciences, 25(12), 6532. https://doi.org/10.3390/ijms25126532

Vancouver

Reschke R, Enk AH, Hassel JC. Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic Targets. International Journal of Molecular Sciences. 2024;25(12):6532. doi:10.3390/ijms25126532

BibTeX
@article{Reschke2024,
  author = {Reschke, Robin and Enk, Alexander H and Hassel, Jessica C},
  title = {Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic Targets},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {12},
  pages = {6532},
  doi = {10.3390/ijms25126532}
}
Kostenlos starten →